FDA Inspection 1205983 — Vetter Pharma Fertigung GmbH & Co. KG

Vetter Pharma Fertigung GmbH & Co. KG — FEI 3002808846

The FDA completed an inspection of Vetter Pharma Fertigung GmbH & Co. KG on May 24, 2022 in Langenargen. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 24, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Langenargen (Germany)

Additional Details

Mutual Recognition Agreement (MRA)